Skip to content
  • Sunday, 26 July 2026
  • 4:31 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • High-Dose Fish Oil Supplements Fail to Slow Cognitive Decline in Older Adults at Risk for Alzheimer’s Disease Despite Successful Brain Penetration
Neuroscience & Brain Research

High-Dose Fish Oil Supplements Fail to Slow Cognitive Decline in Older Adults at Risk for Alzheimer’s Disease Despite Successful Brain Penetration

Rifan Muazin Jun 30, 2026 0

The multi-billion-dollar global industry built around omega-3 fatty acid supplements has faced a significant scientific setback following the release of…

Read More
Neuroscience & Brain Research

Exercise and Low-Dose Ibuprofen Show Promise in Mitigating Chemotherapy-Induced Cognitive Impairment

Rifan Muazin Jun 16, 2026 0

For decades, cancer survivors have reported a cloud of mental fog following treatment, a phenomenon colloquially termed "chemo brain." This…

Read More
Pharmaceutical R&D

UK Approves Lower Dose of Needle-Free Adrenaline Nasal Spray for Young Children

Teuku Ryan Jun 15, 2026 0

The United Kingdom’s Medicines and Healthcare products Regulatory Agency (MHRA) has granted approval for a new, lower dose of ALK-Abelló’s…

Read More
Pharmaceutical R&D

Novo Nordisk’s Wegovy Poised for Significant European Expansion Following Positive CHMP Opinions on Oral and High-Dose Injectable Formulations

Teuku Ryan May 27, 2026 0

The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has delivered two pivotal positive opinions, paving…

Read More
TWiV 1285: Encapsidating Viruses 2025TWiV 1289: Building a better hepatitis B trapMIT Researchers Discover Exercise-Induced Biochemical and Physical Cues Accelerate Nerve Growth and MaturationScience News: A Century of Empowering Public Understanding of Science
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ